Noninvasive estimation of hepatic steatosis using plain CT vs. Chemical‐shift MR imaging: Significance for living donors

To compare plain computed tomography (CT) and chemical‐shift MR imaging (CSI) for establishing a noninvasive method to estimate the degree of steatosis.

[1]  B. Geramizadeh,et al.  Does donor's fatty liver change impact on early mortality and outcome of liver transplantation. , 2007, Transplantation proceedings.

[2]  H. Honda,et al.  Papillary renal carcinoma: Diagnostic approach by chemical shift gradient‐echo and echo‐planar MR imaging , 2006, Journal of magnetic resonance imaging : JMRI.

[3]  H. Hussain,et al.  Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. , 2005, Radiology.

[4]  H. Bonkovsky,et al.  Iron in nonhemochromatotic liver disorders. , 2005, Seminars in liver disease.

[5]  G. Ramm,et al.  Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. , 2005, Seminars in liver disease.

[6]  Y. Maehara,et al.  Short-Term Intensive Treatment for Donors with Hepatic Steatosis in Living-Donor Liver Transplantation , 2005, Transplantation.

[7]  J. Briceño,et al.  Assignment of steatotic livers by the Mayo model for end‐stage liver disease , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  H. Honda,et al.  Comparison of Test-Injection Method and Fixed-Time Method for Depiction of Hepatocellular Carcinoma Using Dynamic Steady-State Free Precession Magnetic Resonance Imaging , 2004, Journal of computer assisted tomography.

[9]  Michael Abecassis,et al.  Dual‐echo, chemical shift gradient‐echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  T. Kim,et al.  Evaluation of the Hepatic Artery in Potential Donors for Living Donor Liver Transplantation by Computed Tomography Angiography Using Multidetector-row Computed Tomography: Comparison of Volume Rendering and Maximum Intensity Projection Techniques , 2003, Journal of computer assisted tomography.

[11]  M. Abecassis,et al.  Liver biopsy in living donors , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  C. Ryan,et al.  One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[14]  P. Ros,et al.  MR imaging in chronic hepatitis and cirrhosis. , 2002, Seminars in ultrasound, CT, and MR.

[15]  Chao-Long Chen,et al.  Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. , 2001, Transplantation.

[16]  S. Kitano,et al.  ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1 , 2001, Transplantation.

[17]  M. Abecassis,et al.  Body mass index as a predictor of hepatic steatosis in living liver donors , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  Y. Yamashita,et al.  Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. , 2001, Radiology.

[19]  E. Siegelman,et al.  Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. , 2001, AJR. American journal of roentgenology.

[20]  H. Rüdiger,et al.  Mechanisms of ischemic injury are different in the steatotic and normal rat liver , 2000, Hepatology.

[21]  R. Fisher,et al.  Single‐center analysis of the first 40 adult‐to‐adult living donor liver transplants using the right lobe , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  C. Avellini,et al.  Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. , 2000, American journal of clinical pathology.

[23]  S. Kitano,et al.  PP-1209 NOVEL ASSESSMENT OF DONOR STEATOSIS FOR LIVER TRANSPLANTATION , 2000 .

[24]  H. Honda,et al.  MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient‐echo imaging , 1999, Journal of magnetic resonance imaging : JMRI.

[25]  E K Outwater,et al.  Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[26]  G. Mancia,et al.  Hepatic iron overload in patients with chronic viral hepatitis: Role of HFE gene mutations , 1998, Hepatology.

[27]  Miguel Angel García Ureña,et al.  Hepatic Steatosis in Liver Transplant Donors: Common Feature of Donor Population? , 1998, World Journal of Surgery.

[28]  J. Ludwig,et al.  Hepatic steatosis as a potential risk factor for major hepatic resection , 1998, Journal of Gastrointestinal Surgery.

[29]  L Dalla Palma,et al.  Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.

[30]  N. Ryley,et al.  Measurement of liver fat by MRI and its reduction by dexfenfluramine in NIDDM , 1997, International Journal of Obesity.

[31]  K. Batts,et al.  Use of fatty donor liver is associated with diminished early patient and graft survival. , 1996, Transplantation.

[32]  N. Rofsky,et al.  CT and MRI of diffuse liver disease. , 1995, Seminars in ultrasound, CT, and MR.

[33]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[34]  C. Compton,et al.  Diagnosis of fatty liver with MR imaging , 1992, Journal of magnetic resonance imaging : JMRI.

[35]  S. Knechtle,et al.  The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. , 1991, Transplantation.

[36]  R. Buxton,et al.  Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. , 1991, AJR. American journal of roentgenology.

[37]  J. Ellis,et al.  Focal fatty infiltration of the liver: demonstration by magnetic resonance imaging. , 1984, AJR. American journal of roentgenology.

[38]  I. Suramo,et al.  Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. , 1983, Scandinavian journal of gastroenterology.

[39]  James Sayre,et al.  Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. , 2004, Radiology.

[40]  J. Hogg.  Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.

[41]  N. L. Johnson,et al.  Multivariate Analysis , 1958, Nature.